Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2009 - 2026)

Idexx Laboratories' Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $44.6 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 449.88% year-over-year to $44.6 million; the TTM figure through Mar 2026 stood at $44.6 million (up 449.88% YoY), while the FY2025 annual figure was $31.9 million, down 75.89% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $44.6 million, up from $31.9 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $132.2 million in Q4 2024, with the low at $2.1 million in Q2 2025.
• The 5-year median for Non-Current Deferred Tax Liability is $8.7 million (2024), against an average of $24.8 million.
• The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability surged 1266.13% in 2023, then plunged 79.17% in 2025.
• Idexx Laboratories' Non-Current Deferred Tax Liability stood at $8.2 million in 2022, then soared by 1266.13% to $111.3 million in 2023, then increased by 18.73% to $132.2 million in 2024, then slumped by 75.89% to $31.9 million in 2025, then soared by 39.95% to $44.6 million in 2026.
• Business Quant data shows IDXX's Non-Current Deferred Tax Liability at $44.6 million in Q1 2026, $31.9 million in Q4 2025, and $3.7 million in Q3 2025.